Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,365,492
-
Share change
-
-157,718
-
Total reported value
-
$9,342,000
-
Price per share
-
$2.14
-
Number of holders
-
22
-
Value change
-
-$436,505
-
Number of buys
-
11
-
Number of sells
-
9
Institutional Holders of ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) as of Q1 2021
As of 31 Mar 2021,
ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,365,492 shares.
The largest 10 holders included
Pivotal bioVenture Partners Investment Advisor LLC, TPG Group Holdings (SBS) Advisors, Inc., RENAISSANCE TECHNOLOGIES LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Squarepoint Ops LLC, Janney Montgomery Scott LLC, CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.